Notícias

Cade e ANPD debatem proteção de dados e concorrência

FTC Authorizes Compulsory Process for AI-related Products and Services

FTC, California Obtain Order Against DNA Testing Firm over Charges it Made a Myriad of Misrepresentations to Consumers to Entice Them to Buy Ancestry Reports

Commission fines Rabobank €26.6 million over Euro-denominated bonds trading cartel

Commission carries out unannounced inspections in the online food delivery sector

AdC adotou uma decisão de não oposição na operação de concentração 65/2023 – Conclusion Iberia / Neotalent.

Referral of the proposed West Midlands Bus Recovery Grant by the West Midlands Combined Authority

Reviews of three merger undertakings and one market investigation Order

Consultation on reviews of three merger undertakings and one market investigation Order

Casos

CADE

Atos de concentração aprovados

Ato de Concentração nº 08700.007826/2023-19. Requerentes: Elétron Power Geração e Comercializadora de Energia S.A. e Riacho Energias Renováveis Ltda. Advogados: Rodrigo Zingales Oller do Nascimento. Decido pela aprovação sem restrições.

Ato de Concentração nº 08700.007822/2023-31. Requerentes: Banco BTG Pactual S.A., ContaAzul International Holdings Corporation e ContaAzul Software Ltda. Advogados: Eduardo Caminati, Marcio Bueno, Jéssica Gusman e Clara Lim. Decido pela aprovação sem restrições.

Ato de Concentração nº 08700.007669/2023-41. Requerentes: QatarEnergy LNG Investments e PetroChina Investment (Hong Kong) Limited. Advogados: Barbara Rosenberg, Luís Bernardo Coelho Cascão e outros. Decido pela aprovação sem restrições.

Ato de Concentração nº 08700.007668/2023-05. Requerentes: QatarEnergy LNG Investments e PetroChina Investment (Hong Kong) Limited. Advogados: Barbara Rosenberg, Luís Bernardo Coelho Cascão e outros. Decido pela aprovação sem restrições.

FTC

CRI Genetics, FTC and State of California v.

In November 2023, the FTC announced that California-based CRI Genetics, LLC (CRI) will pay a $700,000 civil penalty and will be barred from a wide range of deceptive practices to settle charges from the Commission and the California Attorney General that the company deceived users about the accuracy of its DNA reports.

Type of Action

Federal

Last Updated

November 21, 2023

Case Status

Pending

CMA

• Theramex/European Rights to Viatris’ Femoston and Duphaston productsThe CMA is investigating the acquisition by Theramex HQ UK Limited of certain rights to Viatris Inc’s Femoston and Duphaston products.
  • Updated: 21 November 2023